KRT17 and dysplasia: Regauer S & Reich O (2007) maintained that metaplasia showed a strong expression for CK17 marker while dysplasia was negative for CK17; they suggested that CK17 marker can be employed in IHC method to differentiate metaplasia from dysplasia, which is a finding in line with that of the present study (15).